344 related articles for article (PubMed ID: 6787175)
21. [Properties of intestinal monoamine oxidase in the rat].
Verevkina IV; Asnina VV; Gorkin VZ
Vopr Med Khim; 1982; 28(2):88-93. PubMed ID: 7080482
[TBL] [Abstract][Full Text] [Related]
22. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Riederer P; Youdim MB
J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
[TBL] [Abstract][Full Text] [Related]
23. Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity.
Grimsby J; Zentner M; Shih JC
Life Sci; 1996; 58(9):777-87. PubMed ID: 8632725
[TBL] [Abstract][Full Text] [Related]
24. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
25. Effects of cyanide in vitro on the activity of monoamine oxidase in striatal tissue from rat and pig.
Cassel GE; Persson SA; Stenström A
Biochem Pharmacol; 1994 Feb; 47(3):499-504. PubMed ID: 8117318
[TBL] [Abstract][Full Text] [Related]
26. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
[TBL] [Abstract][Full Text] [Related]
27. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
Sivam SP
Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
[TBL] [Abstract][Full Text] [Related]
28. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
29. Some properties of monoamine oxidase in carp heart.
Yamamoto M; Kobayashi S; Oguchi K
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 78(1):117-22. PubMed ID: 6146456
[TBL] [Abstract][Full Text] [Related]
30. Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference.
Meyerson LR; Fuller RW
Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):581-4. PubMed ID: 30122
[TBL] [Abstract][Full Text] [Related]
31. Monoamine oxidase activities in catfish (Parasilurus asotus) tissues.
Kumazawa T; Seno H; Ishii A; Suzuki O; Sato K
J Enzyme Inhib; 1998 Aug; 13(5):377-84. PubMed ID: 9793841
[TBL] [Abstract][Full Text] [Related]
32. Human brain monoamine oxidase: solubilization and kinetics of inhibition by octylglucoside.
Pearce LB; Roth JA
Arch Biochem Biophys; 1983 Jul; 224(2):464-72. PubMed ID: 6870271
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
34. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
35. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.
O'Carroll AM; Fowler CJ; Phillips JP; Tobbia I; Tipton KF
Naunyn Schmiedebergs Arch Pharmacol; 1983 Apr; 322(3):198-202. PubMed ID: 6408492
[TBL] [Abstract][Full Text] [Related]
36. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
Garrick NA; Murphy DL
Psychopharmacology (Berl); 1980; 72(1):27-33. PubMed ID: 6781004
[No Abstract] [Full Text] [Related]
37. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.
Koide Y; Kobayashi K
Neurochem Res; 1984 May; 9(5):595-606. PubMed ID: 6472564
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
Paterson IA; Juorio AV; Berry MD; Zhu MY
J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
[TBL] [Abstract][Full Text] [Related]
39. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain.
Ross SB
J Neurochem; 1987 Feb; 48(2):609-14. PubMed ID: 3098921
[TBL] [Abstract][Full Text] [Related]
40. Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study.
Arai R; Kimura H; Nagatsu I; Maeda T
Brain Res; 1997 Jan; 745(1-2):352-6. PubMed ID: 9037433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
